Toggle Menu
Alibaba local delivery service on the road
Alto is building the world's most patient-centric pharmacy.
Woman working on vehicle programming in production facility

Shared Vision, Amplified Ambition

Alibaba Local Services is redefining urban lifestyle and bringing greater joy and convenience to consumers.

Alto is building the world's most patient-centric pharmacy.

Aurora is delivering the benefits of self-driving technology safely, quickly, and broadly.

Couple in New Delhi, India looking at computer together
Policybazaar
01  —

We believe the most meaningful impact requires patience, and a long-term, scalable vision

Policybazaar is making insurance in India fair, transparent, and sustainable.

Aerial photo of Victoria Peak, Hong Kong
Beike
02  —

We believe that market leadership requires deep courage—from founders and the investors that back them

Beike is using technology to bring reliability and transparency to China's real estate market.

Masayoshi Son
03  —

We believe constant evolution is our most powerful competitive advantage

Masayoshi Son is leading SoftBank Group.

Building a great company takes time. We’re here to support the journey.

We believe that the AI revolution is here. Our portfolio companies are leading the way.

Wide-ranging experience, global connections, and a collective drive to help founders build market-leading companies.

Stories, data, and perspectives from our portfolio companies to help founders make more informed decisions.

SoftBank Vision Fund Grab Delivery
Grab
01  —

We believe great companies are made greater by the company they keep

Grab is driving Southeast Asia forward by improving quality of life for everyone.

SoftBank Vision Fund Bytedance
ByteDance
02  —

We believe that a founder’s ambition determines a company’s potential

ByteDance is enabling people to discover and create a world of content powered by technology.

SoftBank Vision Fund Roivant
Roivant
03  —

We believe in the transformative power of technology

Roivant is rapidly developing innovative medicines through a novel form of industrial organization in R&D.